Seminoma clinical trials
The registry lists 37 studies for Seminoma across more than 10 countries. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-18.
Status
- Recruiting
- 14
- Active, not recruiting
- 8
- Completed
- 7
- Terminated
- 4
- Status unknown
- 3
- Not yet recruiting
- 1
Phase
- Phase 2
- 17
- Phase 3
- 5
- Phase 1
- 2
Where
- United States
- 14
- United Kingdom
- 6
- France
- 6
- Canada
- 5
- Germany
- 5
- Switzerland
- 3
Who runs them
National Cancer Institute (NCI) (4) · Heinrich-Heine University, Duesseldorf (2) · Medical Research Council (2) · N.N. Petrov National Medical Research Center of Oncology (2) · AHS Cancer Control Alberta (1) · Sahlgrenska University Hospital (1) · Haukeland University Hospital (1) · Istituto Clinico Humanitas (1)
Studies
Recruiting first, then most recently updated. Showing 37 of 37 — search for more.
- De-escalation Study for Stage IIa/IIb < 3 cm SeminomaRecruitingNCT05529251Phase 21 country
- Sentinel Node Identification Using Gamma and Near-Infrared Imaging in TesticulAr MaLignanciesRecruitingNCT077778871 country
- PRISTINE Trial: PRoton Beam Therapy In Seminoma - Toxicity INvestigation and Evaluation of OutcomeNot yet recruitingNCT07601672Not applicable
- Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell TumorsRecruitingNCT07218913Phase 11 country
- Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular CancerRecruitingNCT07498959Not applicable1 country
- Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote MonitoringRecruitingNCT05500391Phase 21 country
- THERApy De-escalation for TESTicular CancerRecruitingNCT063097451 country
- R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular SeminomaRecruitingNCT05345158Not applicable1 country
- PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLNDRecruitingNCT06144736Phase 21 country
- Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular CancerRecruitingNCT06133543Not applicable1 country
- High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsRecruitingNCT06418789Phase 21 country
- A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal MetastasesRecruitingNCT06932458Phase 21 country
- Radiotherapy Vs Observation for Post Chemotherapy Residual Mass in Advanced SeminomaRecruitingNCT05142982Not applicable1 country
- MicroRNA as Markers in Testicular CancerRecruitingNCT049140262 countries
- Therapeutic Strategy Guided by PET-TDM for Patients With SeminomaRecruitingNCT01887340Phase 21 country
- Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell TumorsActive, not recruitingNCT03158064Phase 21 country
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 22 countries
- Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell TumorsActive, not recruitingNCT02375204Phase 312 countries
- Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular SeminomaActive, not recruitingNCT02537548Not applicable1 country
- A Study of miRNA 371 in Patients With Germ Cell TumorsActive, not recruitingNCT044357563 countries
- Reduced Intensity Radio-chemotherapy for Stage IIA/B SeminomaActive, not recruitingNCT03937843Phase 22 countries
- A Phase II Trial of Cabozantinib With Patients With Refractory GCTsActive, not recruitingNCT04876456Phase 21 country
- Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular CancerActive, not recruitingNCT02341989Phase 31 country
- Therapy De-escalation in Seminoma Stage IIA/BTerminatedNCT01593241Phase 22 countries
- ARQ 197 for Participants With Relapsed or Refractory Germ Cell TumorsTerminatedNCT01055067Phase 23 countries
- Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With CancerCompletedNCT01037790Phase 21 country
- Carboplatin AUC-10 With Early PET Scanning in Metastatic SeminomaCompletedNCT02272816Phase 21 country
- DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or SiblingsCompletedNCT014343551 country
- Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular TumoursStatus unknownNCT032622071 country
- Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell TumorsCompletedNCT00957905Phase 21 country
- Palifosfamide in Treating Patients With Recurrent Germ Cell TumorsTerminatedNCT01808534Phase 21 country
- Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer PatientsCompletedNCT007050941 country
- Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular CancerCompletedNCT00003014Phase 37 countries
- Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the TesticleStatus unknownNCT00589537Phase 31 country
- Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I SeminomaStatus unknownNCT00004219Phase 3
- Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerCompletedNCT00060372Phase 11 country
- Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian CancerTerminatedNCT00042952Phase 21 country